After repeated IM administration of BPC157 at 30 g/kg for seven consecutive days, the plasma concentration versus time curve was similar to that observed after a single IM injection of 30 g/kg (Figure 2C)
A deficiency can lead to symptoms like lethargy and weakness, making it harder to tackle daily tasks
Human Trials and Development Termination Between 2001 and 2007, Metabolic Pharmaceuticals conducted several human trials evaluating AOD-9604 for obesity management
No serious adverse events, hospitalization, organ damage, or deaths have been documented in over 100 preclinical studies, even at doses 1,000 times higher than typical therapeutic use
Unlike standard sterile water intended for single use, bacteriostatic water supports repeated withdrawals without compromising solution integrity when handled properly